Medications
Semaglutide vs tirzepatide: what the direct trial answers
The strongest comparison concerns specific injectable doses, a defined population and 72 weeks of follow-up.
Medication research
Good decisions start with better questions
Side effects
Constipation on GLP-1 treatment: frequency and follow-up
A common adverse event still needs a plan, especially when symptoms persist or change.
Heart health
GLP-1 cardiovascular benefits: who SELECT actually studied
Relative risk, absolute difference and baseline cardiovascular disease all matter.